PLG and Stroke: Additionally, treatment using this plasmin nanoformulation showed an improved stroke outcome in a photothrombotic stroke model, indicating that it could be used as an efficient and safe thrombolytic agent compared to free plasmin treatment, without causing significant hemorrhagic risk.